HOME >> BIOLOGY >> NEWS
'Plants for the future': A European vision for plant biotechnology towards 2025

Today, the "Plants for the Future" European Technology Platform on plant genomics and biotechnology, launches a new era for plant biotechnology in Europe.

This long term vision for 2025 has been created by leading representatives from research (such as EPSO, the European Plant Science Organisation), the food and biotech industry (such as EuropaBio, CIAA, ESA), the farming community (such as COPA/COGECA) and consumer organisations (BEUC). The vision document has been presented to European Commissioner Busquin.

"Our society faces tremendous challenges in the coming decades. There will be an increased demand for healthier, higher quality and more diverse food. The need for animal feed will grow. Agricultural production needs to become more environmentally friendly: maintaining productivity while reducing inputs including water, pesticides, fertilisers, energy. The issue of economical sustainability will necessitate the development of novel biomaterials, bioenergy and renewable resources. Agriculture will also face consequences of climatic changes causing drought and spread of diseases to new areas of Europe and beyond. It is imperative that we enable developing countries to achieve self-sufficiency and become more competitive and, together with North America, to contribute to meeting the growing global food demands," says Marc Zabeau, chair of EPSO.

These immense challenges can be met by prioritizing basic and applied research goals that are tailored to the needs of European society and the agriculture and the food industries. The expertise and capabilities of European plant scientists also need to be effectively harnessed to generate a more profound understanding of plant biology. Together this new set of capabilities and priorities will enable key characteristics such as improved quality and nutrition, sustainable production, safe co-existence, and improved yield, harvestability, processability and environmental stability to be created, Nove
'"/>

Contact: Karin Metzlaff
Karin.Metzlaff@psb.ugent.be
0032-9-331-3810
VIB, Flanders Interuniversity Institute of Biotechnology
24-Jun-2004


Page: 1 2

Related biology news :

1. European common frog found to use novel mating strategy
2. Zoonotic diseases - European scientists unite to fight diseases
3. Second call for proposals for the European Young Investigator Award
4. Common call for action on European Research Council (ERC)
5. EURYI Award given for the first time to 25 young European researchers
6. European researchers tackle mitosis
7. Key principles for the foundation of a European Research Council (ERC)
8. EC boosts European electron microscopy research
9. European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer
10. Limited climate tracking in European trees despite 10,000 years of postglacial warmth
11. ESA consults European science community on candidate Earth Explorer missions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/7/2019)... ... May 07, 2019 , ... ... Long Beach Convention and Entertainment Center from May 15- 17. At booth #226, ... solutions. These include flexible software, biometric hardware, mobile apps, specialized industry solutions, advanced ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global ... announces today that Holotype HLA and other Omixon products will be featured in ... Immunogenetics (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s ...
(Date:5/2/2019)... (PRWEB) , ... May 01, 2019 , ... ... Board of Directors has appointed John Rakow, the Company’s General Counsel, as Interim ... Richman and Zac Apte, are currently on administrative leave. There will also be ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is excited to ... the presidential line of succession, at the 22nd Annual Meeting . Members of ... three-year term (2019-2021). , All five incoming members of the ASGCT Board of ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , a ... latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions to ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
Breaking Biology Technology:
Cached News: